Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks for the update.
I’ve been thinking there may be something to the higher volumes and HFT. SGLB has a beta of ~ -1, meaning that it mostly moves inversely to the market. Down days in the market (yesterday), we see SGLB pop, and vice versa. At least it’ll be something to watch for as we watch the paint dry...
Probably to control costs. Board members cost money. Time value of money simply states that money in my pocket now is generally worth more than later. It’s usually the reason businesses don’t pay their bills the date they receive them unless there’s a discount for doing so.
I could see the argument made both ways, though. I’m sure that having a delisting notice doesn’t bode well for current shareholders or enticing institutional investors...however, that didn’t seem to stop the significant volume traded after the last PR. Also, I’m pretty sure the warrants would be worthless unless they remained on the NASDAQ exchange.
They've announced upgrades without any indication of increased revenues, so I think they'd announce increased orders, especially if they're trying to raise more capital/entice new investors/be in compliance of NASDAQ's listing requirements.
Honestly, not sure. I haven't dug through it. Ted's explanation makes sense. I think management would also include industry and business related updates (product upgrades, etc).
This site provides a simple breakdown of the prospectus amendment.
It says,
Anyone else having trouble with the webcast?
Yeah, but this is the first time I've seen their COGS be more than their revenue. Looks like at this scale, upsale won't fund operations. I guess that should be obvious, but it is interesting.
Hey silversmith,
It seems like you've reached your tipping point despite remaining positive in definitely worse circumstances. I've appreciated your opinion in the past, would you mind giving the full disclosure of your grievances? I'd like to hear your thoughts.
Thanks.
I think the JTDA with GE gave more away than anticipated.
Gonna have to change your nick ;)
Yeah, I imagine they'd want the tech to corner the market for 3d printed critical parts.
I'm sure you can understand why posting partial facts can cause there to be confusion about the stock.
However...I agree that everyone needs to read every filing/footnote that the company puts out.
You forgot this important part...
Doesn't that just have to do with outstanding shares - to adjust for splits, stock dividends, offerings, etc? There aren't enough shares for 100 shares per warrant. Even still, why would round 1 up to 100? Please explain.
Join the webcast @ 4:30 PM EST: Click here
Are you saying you don't understand what he's saying because you didn't read past the 1st page so you decided to talk about the proposal to raise the authorized shares?
If I found the right Dennis Duitch...he's from Los Angeles...close to Morf3D's HQ.
Looking at the New Mexico Angels' website, it looks like they did invest in some companies...including an unnamed one in Santa Fe:
I thought he was brought in this past February?
From Morningstar:
Makes more sense when you put it that way. I was referring to the remark you made about reading what they said instead of using my imagination.
I wish I could fully understand what they mean by what they wrote, but I believe we need more details. This is like reading a scientific paper without any of the numerical results...it's hard to interpret. I agree with your conclusion it's not positive and they're looking elsewhere because it didn't hit the mark for the targeted expectations - I'm just curious to what degree.
I imagine that they were able to detect CTQs, just not statistically significant enough to be reliable, right?
Yup, and with their claims...I'm not surprised at all the funding they've received.
Started in 10/2015 starting with ~100 million in capital. Now, around 215 million. Definitely a huge benefit of financing with private equity.
The language suggests that he has and continues to work at Sigma Labs.
Excellent SGLB commentary. You should have a newsletter.
They don't...but that's not the question here, which is whether or not the utilization of Sigma's IPQA leads to faster production & reduced costs compared to in-house methods/competition.
We need a flow chart here for the repetition.
Just filling in the missing info?